Newly Added Classes


HRS Learning Center with activities
There are over 50 various activities available with and without credit.
Website


ISHNE ECG UNIVERSITY
Basic ECG Diagnosis Course.
Website


Appropriate Stroke Prevention Strategies in AF: One Size Does Not Fit All
The goal of this activity is to review the use of non-vitamin K antagonist oral anticoagulants (NOACs) to prevent atrial-fibrillation-related stroke in various patient populations. Valid for credit through: 6/18/2019.
Website 


Management of Atrial Fibrillation, Stroke and Bleeding: Evidence From Clinical Practice
Screening for Atrial Fibrillation to Prevent Strokes -- Where Are We Now?, NOAC-Related Intracranial Hemorrhage -- Risk, Clinical Presentation, and Predictors, Oral Anticoagulants: What Did We Learn in Clinical Practice?, and NOACs: Can the Effect Be Reversed in Acute Situations? Valid for credit through: 6/24/2019.
Website 


Managing Embolic Risk in AF Patients With Renal Impairment: Case Considerations
Enhance your clinical skills as you engage with patients in an objective and realistic interactive simulation. Treat patients, diagnose medical conditions, and prescribe medications. There are no limits to your choices—order from thousands of labs, diagnoses, devices, and drugs using an intuitive patient chart-based interface. Powerful metrics track your performance and provide instant expert feedback on your decisions. Upon completion, results will be presented, along with author commentary on each case. Valid for credit through: 6/25/2019.
Website 


Anticoagulants in Interventional Cardiology: Where Are We in 2018?
All sections of this activity are required for credit. An Overview of Anticoagulation in Interventional Cardiology, The Use of NOACs in the Setting of AF and PCI, Exploring the Use of NOACs in the Setting of TAVR and Transitioning Care From Post-Procedure to Long-Term Management. Valid for credit through: 6/26/2019.
Website 


Identifying High-Risk AF Patients: Are Biomarkers the Answer?
The goal of this activity is to increase knowledge in risk stratification and identification of patients who should receive anticoagulation and to gain competence in instituting appropriate antithrombotic therapy in patients at risk for stroke based on clinical trial data. Valid for credit through: 9/25/2019.
Website 


Oral Anticoagulation in AF: From Evidenced-Based Medicine to Daily Clinical Practice
Anticoagulation is a very safe option in patients with AF. The NACS allow physicians to treat elderly, frail patients in whom there is often concerna about the safety of anticoagulation. Real-world data is helpful to understand our practice patterns and to objectivize our fears as healthcare prodessionals, but they are less useful for comparative effectiveness. Valid for credit through: 9/28/2019
Website 


Watching for the Patient With Atrial Fibrillation: Latest Advances and Technologies
This activity is intended for cardiologists, PCPs, neurologists, and nurses. The goal of this activity is to provide an update on the use of left atrial appendage closure (LAAC) devices in the prevention of stroke in patients with atrial fibrillation (AF). CME / ABIM MOC / CE Released: 12/12/2017. Valid for credit through: 12/12/2018
Website 


Concomitant Surgical Ablation of Atrial Fibrillation: Navigating Controversies and Growing Your Practice
The on-demand webcast features expert presentations and engaging discussions, which include a review of current societal guidelines, controversies in surgical ablation, and optimal strategies for overcoming barriers to adopting concomitant surgical AF ablation into daily practice. The expert presentations are complemented with a moderated discussion that thoroughly explores a variety of Hot Topics that impact the cardiothoracic surgical team managing AF patients. CME Released: 3/6/2018; Valid for credit through 3/6/2019
Website


High-Density Mapping in Atrial Fibrillation: The Mount Sinai's Experience
Electrophysiologists at Mount Sinai Medical Center in New York City will share their knowledge of optimal mapping and ablation strategies for managing Atrial Fibrillation. A comprehensive review of clinical decision making strategies will assess the latest technology to manage arrhythmias through a live case as well as a question and answer session.
Website


Rationale and Best Practices for NPAF Treatment: A Roundtable Discussion on the Convergent Approach
Review the theoretical basis for targeting the posterior wall in NPAF patients. Evaluate appropriate patient selection and preoperative testing considerations.Assess the rationale and logistical impacts for sequential and staged cases.Examine the post epicardial ablation voltage map as a guide for endocardial ablation targets.Review different epicardial lesion strategies based upon the expected endocardial ablation device. Identify the top perioperative and postoperative procedural risks and the key mitigation techniques involved in reducing their occurrence. CME Released: 3/12/2018; Valid for credit through 3/12/2019.
Website


Silent No More: What to Do With Newly Diagnosed Atrial Fibrillation
This activity is intended for cardiologists, neurologists, and primary care physicians.The goal of this activity is to increase knowledge and competence regarding the identification of risk factors that are predictive of atrial fibrillation (AF) in asymptomatic patients. CME / ABIM MOC Released: 12/14/2017. Valid for credit through: 12/14/2018
Website


Reducing Stroke Risk in Atrial Fibrillation Patients: Practical Guidance for Anticoagulant Management
The intended audience for this educational initiative includes community cardiologists, general practitioners, and other healthcare providers who are involved in the management of hospitalized patients and out-patients with atrial fibrillation (AFib). Oral anticoagulation can greatly reduce the number of strokes associated with AFib. However, despite the availability of multiple anticoagulant options and recommendations in practice guidelines, these treatments can be underutilized in at-risk patients, leaving them at unacceptably high risk of stroke. CME Released: 12/28/2017 Valid for credit through: 12/28/2018.
Website


Catheter Ablation of VT in Normal Hearts
Reviewing key points on catheter ablation of ventricular tachycardia (VT) in structurally normal hearts 
Website


Catheter Ablation of VT in Structural Heart Disease
Reviewing key points on catheter ablation of ventricular tachycardia (VT) in structural heart disease
Website


Contemporary Review of Mapping and Ablation of Cardiac Arrhythmias
The goal of this activity is to review arrhythmia mechanisms and cardiac anatomy for the EP professional. To review SVT arrhythmia differentiation in the EP lab. To review fundamentals of AF and VT ablation procedures. CME Released: 9/20/2017 Valid for credit through: 9/20/2018 
Website


2017 Remote Monitoring Update Webinar
This 3-part series will highlight recommendations outlined in the 2015 HRS consensus statement:  Remote Monitoring Interrogation and Monitoring for Cardiovascular Implantable Electronic Devices and provide an update on clinical comparative effectiveness studies published since 2015 for remote monitoring. CME Released: 10/10/2017 Valid for credit through: 10/31/2018 
Website


2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation
May 12, 2017 The 2017 Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation represents a complete rewrite of the 2012 HRS/EHRA/ECAS Expert Consensus Statement. This document provides updated definitions, mechanisms, and rationale for atrial fibrillation (AF) ablation and consensus recommendations concerning indications, strategies, techniques, and endpoints, technology and tools, and follow-up considerations for AF ablation.
Website


ADVICE: Adenosine-Guided PVI Ablation Reduces Atrial Tachyarrhythmia Recurrence
The use of adenosine to identify and eliminate dormant pulmonary vein conduction during radiofrequency ablation of paroxysmal atrial fibrillation (AF) significantly reduces recurrent atrial tachyarrhythmias, according to the results of a large, prospective, multicenter trial.
Website


AF and PCI: Tailoring Antithrombotic Therapy to Optimize Outcomes
The goal of this activity is to provide an update on the clinical challenges of treating patients with atrial fibrillation who now need a percutaneous coronary intervention with regard to combining oral anticoagulants and antiplatelet therapy. 
Website


Cardiac Device Infections: Pathologies and Management Implications
Video - By Cleveland Clinic Heart Rhythm Society 2014 Symposium Featuring Sohail Rizwan
Website


Case Presentation: Walking Through a Case of Epicardial VT Ablation
Case Presentation: Walking Through a Case of Epicardial VT Ablation by Dr. Kalyanam Shivkumar, UCLA Health System, Los Angeles, CA. Presented at the Cleveland Clinic Heart Rhythm Society 2014 Symposium.
Website


Catheter Ablation for Ventricular Tachycardia
What is the long-term safety and effectiveness of radiofrequency catheter ablation (RFCA) in patients with coronary artery disease and sustained monomorphic ventricular tachycardia (SMVT)? - See more at: http://www.acc.org/Latest-in-Cardiology/Journal-Scans/2016/02/09/15/36/Long-Term-Success-of-Irrigated-Radiofrequency-Catheter-Ablation?
Website


Challenging Cases in Atrial Fibrillation Management: Issues of Anticoagulation
Challenging Cases in Atrial Fibrillation Management: Issues of Anticoagulation by Dr. Eric Prystowsky, FACC Director of Cardiovascular, St Vincent Hospital, Indianapolis, IN.
Website


CIED infection: Incidence, Predictors, Strategies for Prevention
Featuring Bruce Wilkoff
Website


Comparative Chronic Valve and Venous Effects of Lumenless versus Stylet-Delivered Pacing Leads in Patients with and Without Congenital Heart
A study of 134 pediatric patients with and without congenital heart defects showed that a lumenless 4.1 Fr diameter pacing lead (Medtronic Model 3830) was associated with less adverse impact on atrioventricular valve integrity and venous obstruction compared to 5-7 Fr diameter pacing leads.
Website


Confluent Extended Posterior Left Atrial Wall Ablation: Thinking Inside the Box
Here, we report intermediate follow-up details after using a technique of confluent posterior left atrial wall epicardial ablation designed to eliminate both existing and future atrial fibrillation (AF) substrates. The method is part of the Convergent hybrid procedure for AF ablation.
Website


Cutting the cord: Leadless electrophysiology devices in practice
By Dr. Gaurav Upadhyay, University of Chicago, Chicago, IL. Presented at Innovations in Cardiovascular Therapeutics 2016.
Website


Drivers in Relation to Duration of Persistent Atrial Fibrillation
What are the mechanisms and preferential sites of driver activity in patients with persistent atrial fibrillation (AF)?
Website


ECG of the Month
List of monthly ECG quizzes.
Website

 


How Innovations and Cybersecurity Impact Physicians and the Patients We Treat
Evaluate the importance of maintaining and enhancing medical device integrity in the dynamic and ever evolving cybersecurity environment, while considering the potential patient health, safety and confidentiality impacts of cybersecurity in the context of medical technologies in healthcare. Review the balance for protecting patient safety and promoting the development of innovative technologies and improved technology performance. Review how to ensure the evaluation of cybersecurity is integrated with a holistic assessment of potential impacts on patient health, safety, and security of patient data, and health information, so patient and physician needs are balanced, and clinical perspectives considered with cybersecurity throughout the product lifecycle. Gain understanding of the cybersecurity policies and procedures and communication processes that govern implantable devices throughout the product lifecycle. Gain understanding of evolving communication standards and tools of the future that will enhance cybersecurity of implanted medical devices.
Website


Improve the prevention of sudden cardiac arrest in emerging countries: the Improve SCA clinical study design.
Primary prevention patients with syncope/pre-syncope, non-sustained VT, frequent PVCs, or LVEF < 25% risk factors (categorized as 1.5 Prevention) have been shown to be at similar risk of VT/VF as secondary prevention patients. The Improve SCA study will enroll 4800 ICD-eligible patients from Asia, Latin America, Eastern Europe, the Middle East, and Africa in order to confirm this risk, providing additional geographical-relevant evidence to inform shared decision making.
Website


Improving Persistent AF Ablation Outcomes through a Multidisciplinary Approach
Review large unmet clinical need and challenges of treating persistent AF with current ablation approaches. Evaluate the safety and efficacy of dual epicardial and endocardial ablation for treating persistent or longstanding persistent AF. Assess outcomes data and clinical experiences for comprehensive posterior left atrial ablation in persistent AF patients.
Website


Individual patient data network meta-analysis of mortality effects of implantable cardiac devices.
An individual patient-level meta-analysis of 13 randomized trials (n = 12,638) was performed to estimate the comparative mortality effects of ICDs, CRT-Ps, and CRT-Ds. These data can be used to estimate an individual patient's expected and inform shared benefit decision making.
Website


Journal CME/HeartRhythm Journal: March 2017 Vol. 14, Issue 3: Delayed efficacy of radiofrequency catheter ablation on ventricular arrhythmias originating from the left ventricular anterobasal wall
Ventricular arrhythmias (VAs) originating from the left ventricular anterobasal wall (LV-ABW) may represent a therapeutic challenge. The purpose of this study was to investigate the delayed efficacy of radiofrequency catheter (RFCA) ablation without an epicardial approach on VAs originating from the LV-ABW. RELEASE DATE: 2/15/2017 EXPIRATION DATE: 2/23/2019 CME: 1
Website


Late-Breaking Clinical Trial: "The POWDER-AF Trial"
Several Late-Breaking Clinical Trials were presented at Heart Rhythm 2017. Click on the link below to watch Mattias Duytschaever, MD, PhD review the "Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment In Subjects With Recurrent Atrial Fibrillation: Results From The POWDER-AF Multicentre Randomized Trial"
Website


Magnet Function with Medtronic Cardiac Devices" on Medtronic Academy.
This course and reference tool is designed for physicians, nurses, radiologists, and all other medical personnel managing patients with Medtronic pacemakers and ICDs. It describes: how a magnet affects Medtronic pacemaker and ICD devices, clinical scenarios where a magnet can be used, how to prepare and monitor a patient once the clinician determines a magnet should be used. Must register first through Medtronic.
Website


More Double Trouble: AF and Hypertension CME
Characterize the risk presented by patients with atrial fibrillation (AF) and hypertension Review the clinical trial experience with non-vitamin K antagonist oral anticoagulants (NOACs) vs warfarin in patients with hypertension
Website


Natalia Trayanova, PhD "Reentrant Drivers Anchoring to Structural Heterogeneities: A Major Pathophysiological Mechanism of Human Persistent AF"
The mechanisms underlying persistent atrial fibrillation (AF) in patients with atrial fibrosis are poorly understood. Evidence from recent clinical and experimental studies suggests that persistent AF might be maintained by reentrant drivers (i.e., rotors), but the mechanisms linking reentrant driver formation and persistent AF perpetuation remain unknown.
Website


On the Quest for the Best Freeze: Predictors of Late Pulmonary Vein Reconnections After Second-Generation Cryoballoon Ablation
The second-generation cryoballoon is effective in achieving acute pulmonary vein isolation (PVI) and favorable clinical outcome. To date, no data are available on factors affecting late PV reconnection after second-generation cryoballoon ablation.
Website


Optimizing CRT through Device Programming
The plan reviews CRT device follow-up steps, discusses clinical evidence on the impact of RV pacing, and provides an overview of device algorithms that help ensure delivery of cardiac resynchronization therapy.
Website


Patient Selection in Catheter Ablation for Atrial Fibrillation
Dr. Larry Chinitz, NYU Langone Medical Center, New York, NY. AF Ablation Video.
Website


Periprocedural Management of Anticoagulation
Dr. John Doherty, Thomas Jefferson University Hospital, Philadelphia, PA.
Website


Real-World Safety of NOACs: What Do We Know Today?
The goal of this activity is to improve understanding of real-world evidence regarding NOAC safety and efficacy. 
Website


Stroke Prevention in Atrial Fibrillation: Advancements in Oral Anticoagulation Therapy and LAA Closure
The Program Director, Dr. Vivek Reddy, and world-renowned faculty, explore advancements in Left Atrial Appendage Closure (LAAC) and oral anticoagulation therapy for managing AF related stroke. Session highlights include Case Broadcasts from Mount Sinai Hospital, Device Reviews and Technical Considerations, AF-Related Stroke and Anticoagulation, LAAC Clinical Outcomes, Essentials for Advancing the Clinical Science, and Practical Aspects of LAAC.
Website